Phase 4 ADHD Trial, Recruiting (NCT07169760)

Phase 4 ADHD Trial, Recruiting NCT07169760 Sponsor: Rutgers, The State University of New Jersey Condition: ADHD

Printed from Voxsanity (voxsanity.com.au) — NCT07169760 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Adhd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with ADHD according to standard diagnostic guidelines (DSM-5)
You are between 18 and 25 years old
You experience significant attention and focus difficulties specifically related to homework tasks, based on a screening questionnaire score (confirm with trial site)
You currently have at least 5 inattention symptoms of ADHD that affect your daily life, and had at least 6 such symptoms during childhood
You may still be eligible if you also have oppositional behaviour, anxiety, or depression alongside your ADHD

Who may not be able to join:

You do not have a formal ADHD diagnosis
You are outside the 18–25 age range
You have a history of seizures (as the trial uses virtual reality technology)
You have autism spectrum disorder, bipolar disorder, obsessive-compulsive disorder, or active substance abuse problems
You have certain other psychiatric conditions whose treatment would prevent you from taking part (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Joshua M Langberg, PhD, Rutgers University

Phone: (848) 445-2000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07169760

Sponsor: Rutgers, The State University of New Jersey

Phase: Phase 4

Status: Recruiting

Condition: ADHD

Trial contact: (848) 445-2000

More information: https://clinicaltrials.gov/study/NCT07169760

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with ADHD according to standard diagnostic guidelines (DSM-5)
You are between 18 and 25 years old
You experience significant attention and focus difficulties specifically related to homework tasks, based on a screening questionnaire score (confirm with trial site)
You currently have at least 5 inattention symptoms of ADHD that affect your daily life, and had at least 6 such symptoms during childhood
You may still be eligible if you also have oppositional behaviour, anxiety, or depression alongside your ADHD

Who may not be able to join:

You do not have a formal ADHD diagnosis
You are outside the 18–25 age range
You have a history of seizures (as the trial uses virtual reality technology)
You have autism spectrum disorder, bipolar disorder, obsessive-compulsive disorder, or active substance abuse problems
You have certain other psychiatric conditions whose treatment would prevent you from taking part (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Rutgers, The State University of New Jersey

Registry

ClinicalTrials.gov

Start date

9 September 2025

Est. completion

1 September 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Concentration; On-task Behavior

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov